title: [Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder].
authors.forename: C
authors.initials: C
authors.lastname: Brénuchon
authors.forename: D
authors.initials: D
authors.lastname: Launay
authors.forename: C A
authors.initials: CA
authors.lastname: Maurage
authors.forename: V
authors.initials: V
authors.lastname: Queyrel
authors.forename: M
authors.initials: M
authors.lastname: Lambert
authors.forename: H D
authors.initials: HD
authors.lastname: N'Guyen
authors.forename: N
authors.initials: N
authors.lastname: Boutry
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
authors.forename: P Y
authors.initials: PY
authors.lastname: Hatron
authors.forename: B
authors.initials: B
authors.lastname: Devulder
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002081:Buttocks; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D006984:Hypertrophy / Q000209:etiology; D008297:Male; D019042:Muscle Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D018482:Muscle, Skeletal / Q000473:pathology*; D009135:Muscular Diseases / Q000209:etiology; D009364:Neoplasm Recurrence, Local; D013848:Thigh; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000473:pathology*; D000093542:Gemcitabine
chemical_list: D000305:Adrenal Cortex Hormones; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine